AI Article Synopsis

  • The human cornea is made up of multiple layers and types of cells, which can lose their ability to divide as people age, leading to vision problems and diseases.
  • Corneal transplants are a common solution for vision restoration, but there's a limited number of donor tissues, sparking interest in creating lab-grown alternatives.
  • Research has shown that manipulating specific genes and conditions can allow corneal endothelial cells to replicate indefinitely, leading to the development of stable cell lines that could enhance future treatments for corneal issues.

Article Abstract

The human cornea is a tri-laminar structure composed of several cell types with substantial mitotic potential. Age-related changes in the cornea are associated with declining visual acuity and the onset of overt age-related corneal diseases. Corneal transplantation is commonly used to restore vision in patients with damaged or diseased corneas. However, the supply of donor tissue is limited, and thus there is considerable interest in the development of tissue-engineered alternatives. A major obstacle to these approaches is the short replicative lifespan of primary human corneal endothelial cells (HCEC). Accordingly, a comprehensive investigation of the signalling pathways and mechanisms underpinning proliferative lifespan and senescence in HCEC was undertaken. The effects of exogenous human telomerase reverse transcriptase expression, p53 knockdown, disruption of the pRb pathway by over-expression of CDK4 and reduced oxygen concentration on the lifespan of primary HCEC were evaluated. We provide proof-of-principle that forced expression of telomerase, when combined with either p53 knockdown or CDK4 over-expression, is sufficient to produce immortalized HCEC lines. The resultant cell lines express an HCEC-specific transcriptional fingerprint, and retain expression of the corneal endothelial temperature-sensitive potassium channel, suggesting that significant dedifferentiation does not occur as a result of these modes of immortalization. Exploiting these insights into proliferative lifespan barriers in HCEC will underpin the development of novel strategies for cell-based therapies in the human cornea.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3440103PMC
http://dx.doi.org/10.1111/j.1474-9726.2011.00776.xDOI Listing

Publication Analysis

Top Keywords

corneal endothelial
12
human corneal
8
endothelial cells
8
human cornea
8
lifespan primary
8
proliferative lifespan
8
p53 knockdown
8
human
5
corneal
5
hcec
5

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!